BlackBerry與百度擴大合作推動發展下一代自動駕駛技術
加拿大軟件商黑莓(BlackBerry)(BB.US)宣布擴大與百度(BIDU.US)的戰略合作夥伴關係,以推動下一代自動駕駛技術的發展,並且在百度高清地圖等自主軟件整合到黑莓QNX車載操作系統後,搭載這個系統的廣汽集團(02238.HK)電動車Aion將會量產。
黑莓表示,在QNX操作系統與百度的Apollo平台整合後,百度在為創新技術建立商業生態系統方面取得重大進展,期望日後繼續與百度緊密合作,以協助開發及部署自動駕駛及互聯汽車技術。而百度則表示,希望能與黑莓共同為車廠提供一個快速生產自動駕駛汽車的方法。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.